VRDN
Viridian Therapeutics Inc
20.50$
-0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 83.9% | 90.9% | 100.0% | 98.8% | 98.8% | 98.3% | 98.7% | 98.3% | 97.6% | 99.2% | 99.5% | 99.4% | |
| 63.3% | 84.0% | 78.4% | 90.4% | 49.3% | 82.1% | 35.0% | 20.8% | 35.8% | 21.0% | 13.4% | 23.6% | |
| 63.3% | 84.0% | 78.4% | 90.4% | 94.5% | 88.7% | 97.2% | 96.7% | 97.6% | 97.3% | 96.7% | 97.2% | |
| 13.5% | 3.1% | 12.3% | 2.8% | 0.0% | 0.4% | – | 0.2% | 0.0% | 0.0% | – | – | |
| 2.2% | 1.4% | 1.5% | 0.0% | – | – | – | – | -1.5% | – | – | – | |
| – | – | 14.7% | 1.1% | 1.1% | 1.7% | 0.6% | 0.2% | 0.3% | – | – | – | |
| 25.9% | 19.3% | 107.7% | 26.6% | 22.4% | 47.9% | 8.5% | 7.9% | 9.2% | 9.9% | 9.5% | 19.7% | |
| 24.6% | 19.1% | 107.7% | 7.4% | 10.2% | 33.6% | 8.1% | 6.7% | 7.7% | 5.4% | 6.4% | 7.9% | |
| 1.0% | 8.6% | 24.5% | – | 3.5% | 13.1% | 0.3% | 0.3% | 0.1% | 0.2% | 0.1% | 0.1% | |
| 3.2% | 1.9% | 3.7% | 1.7% | 0.9% | 3.6% | 0.5% | 1.1% | 3.3% | 0.5% | 0.3% | 1.0% | |
| – | – | – | 18.9% | 12.1% | 14.3% | – | – | 1.1% | 4.1% | 2.8% | 5.6% | |
| 74.1% | 80.7% | -7.7% | 73.4% | 77.6% | 52.1% | 91.5% | 92.1% | 90.8% | 90.1% | 90.5% | 80.3% | |
| -82.1% | -139.3% | -719.5% | -178.3% | -190.9% | -555.7% | -212.5% | -175.9% | -112.2% | -148.0% | -134.1% | -148.8% | |
| 1.9% | 4.2% | 16.9% | 2.4% | 3.0% | 6.9% | 2.7% | 5.9% | 7.4% | 9.1% | 9.1% | 9.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.